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lagen binding activity to antigen ratio (VWF:CB/Ag) and the percentage of
high molecular weight multimers of VWF (%HMWM) did not change after
exercise in the non obstructive group but were lowered in patients with latent
obstruction (both p=0.003). Incomplete SAM at rest was the strongest inde-
pendent predictor of%HMWM drop (r=-0.70, p<0.0001). %HMWM after
exercise tightly correlated with exercise peak gradient (r=-0.78, p<0.0001) and
the persistence of obstruction during recovery (r=-0.67, p=0.005).
Conclusion: Incomplete SAM and mitral S velocity at rest are the main
predictors of latent obstruction in HCM. Latent obstruction elicits a rapid
cleavage of the largest multimers of VWF which is related to the peak gra-
dient but also to the persistence of obstruction during recovery.
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Implementation of patients reaction is better than implementation of
knowledge in Heart failure patients
Patrick Jourdain, Joël Dagorn, François Funck, Michel Bellorini, Jean Loi-
ret, Michel Desnos
CH R Dubos, UT d’insuffisance cardiaque, Pontoise, France
Heart failure remains a disease with poor prognosis despite the therapeutic
advances of recent decades. Nearly a third of hospital admissions are due to
errors in dietetics follow up or therapeutic monitoring. Therapeutic education
of patients with heart failure is growing fast in France. For the "Haute autorité
de santé" (HAS), evaluation of education programs is an essential element in
the same way that the educational diagnosis and interactivity. We wanted to
determine what the assessment could predict the onset of the test combined
death and hospitalization for heart failure.
We included 398 patients with systolic heart failure who received a thera-
peutic education between 2003 and 2008. The program involved an educa-
tional diagnosis individual training sessions with the disease, sessions
Implementation situation, self-physical and dietary. During this educational
process, patients filled a questionnaire initial knowledge (Q1) and a question-
naire at the end of training (Q2) and one year of it (Q3). They also fulfilled a
clinical case assessment and post training within one year.
The average age of patients was 65 (± 4), LVEF of 34 (± 4), the average
BNP of 235 (± 346). There is no correlation between the scores of knowledge
questionnaires and questionnaires of clinical cases. In ROC curve there is no
cut off for predicting the occurrence of a major event. In survival curve there
is no difference between patients having a response greater than the median at
questionnaire1, 2 or 3. however patients with a clinical performance at post
training clinical cases above the median had an event-free survival signifi-
cantly better than those with a response below the median (p <0001).
Conclusion: The evaluation of the reactions of patients with clinical cases
is greater than the simple evaluation of the knowledge of patients in terms of
predicting survival without hospitalization for heart failure.
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Determinants of B-type natriuretic peptide levels and left atrial
volume in stable patients in sinus rhythm: an echocardiographic-
catheterization study
Marie-Perrine Jaubert (1), Stéphane Arques (2), Alexane Nicoud (1), Lau-
rent Bonello (1), Pascal Sbragia (1), Sébastien Armero (1), Franck Paga-
nelli (1)
(1) Hôpital Nord, Marseille Cedex 15, France – (2) CH Aubagne, Auba-
gne, France
Background: B-type natriuretic peptide (BNP) (Advia Centaur System) and
left atrial volume index (LAVi) are regarded as powerful markers of global myo-
cardial function. Several confounding factors are known to potentially influence
this relation. The aim of the present study was to evaluate the determinants of BNP
and LAVi in the same population of stable patients referred for catheterism.
Methods: 74 consecutive patients were included. Exclusion criteria were
arrhythmias, acute coronary syndrome, exacerbation of heart failure and severe
left-sided valve disease. All the data were obtained within the same morning for
each patient. All following variables were tested: age, gender, body mass index,
systolic arterial pressure, heart rate, LV ejection fraction (LVEF), LV mass index
(LVM), significant mitral regurgitation (MR), serum hemoglobin (Hb), creatinine
clearance (CC), LV end-diastolic pressure (LVEDP), extent of coronary disease.
Results: Univariate determinants of BNP were age, LVEF, LVM, MR,
LVEDP, extent of coronary disease, Hb and CC. By multiple regression anal-
ysis, the independant determinants of BNP were age, LVEDP and LVEF
(p<0,005 for all). Univariate determinants of LAVI were age, significant MR,
LVM, LVEF and LVEDP. By multiple regression analysis, the independent
predictors were LVM and LVEDP (p=0,001 for all). BNP was not predicted
by LAVi in the multivariate model.
Conclusion: Our study confirms that both BNP and LAVi can be used as
markers of global myocardial dysfunction in stable patients in sinus rhythm. How-
ever, age must be taken into consideration before interpreting BNP results.
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Rationale: The part of elderly patients (pts) in heart failure (HF) popula-
tion is growing. They might pose specific problems due to the greater propor-
tion of HF with preserved LVEF, more frequent comorbidities or contra-
indications to recommended HF treatment.
Objectives: to describe the care management of pts > 80-year treated for
HF in France.
Methods: Cross sectional observational survey with retrospective collec-
tion of data at hospital discharge. Pts must have been diagnosed with CHF and
have been hospitalised for CHF within the previous 18 months. Pts are classi-
fied according to the LVEF at hospital discharge.
Results: 412 French outhospital cardiologists entered 1 452 pts meeting the
inclusion criteria. FEVG at hospital discharge was known for 1408 pts. 355
(25%) were more than 80-year-old. Management care at hospital discharge
according to age and LVEF is detailed below.
 
 
LVEF 
< 40%
LVEF 
40-50%
LVEF 
> 50% Total
Age>80
 
 
 
 
 
 
ACEI/ARB 84% 81% 80% 82%*
BB 71% 67% 40%†‡ 62%*
Loop diuretics 92% 85% 85% 88%
Spironolactone/eplerenone 26% 20% 18% 22%*
Digoxin 20% 15% 29% 21%*
Calcium antagonists 10% 14% 37%†‡ 18%
Anticoagulants 49% 45% 51% 49%*
Age≤80
 
 
 
 
 
 
ACEI/ARB 93% 93% 85%†‡ 92%
BB 79% 78% 76% 79%
Loop diuretics 90% 82% 79%†§ 86%
Spironolactone/eplerenone 35% 21% 25%†§ 30%
Digoxin 16% 15% 16% 15%
Calcium antagonists 9% 19% 21%†§ 13%
Anticoagulants 42% 39% 39% 41%
†p<0.05 for comparisons between LVEF > 50% and LVEF<40%; 
‡ p<0.05 for comparisons between LVEF>50% and LVEF between 40% 
and 50%; 
§: p<0.05 for comparisons between LVEF<40% and LVEF between 40% 
and 50%; 
* p<0.05 for comparisons between > 80 and ≤ 80 years old adjusted for 
LVEF.
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Conclusion: BB, ACEI/ARB, spironolactone/eplerenone are less often pre-
scribed in elderly patients contrasting with digoxin and anticoagulants pre-
scription. These differences persist after adjustment on LVEF.
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Background: The prevalence of anaemia in chronic heart failure (CHF)
ranges widely from 4 to 70% due to a lack of an established consistent defi-
nition of anaemia in CHF. Furthermore haemodilution impacts haemoglo-
bin concentrations and could be an important cause of anaemia in CHF.
Aims: The IMPACT-RECO program III analysed the impact of NYHA
class of CHF and of comorbidities on therapeutic management of French
outpatients with stable CHF and left ventricular systolic dysfunction.
Methods: This survey was carried out from March 2007 to December 2007
among randomly selected French private cardiologists. 1574 patients with
CHF and left ventricular ejection fraction (LVEF) < 40% were included.
Results: Mean age was 71 ± 11 years, 75% of the patients were men,
34% were in NYHA class III-IV, 54% had coronary artery diseases, 30%
had atrial fibrillation and the mean LVEF was 34 ± 7%. Haemoglobin
concentration was recorded in 953 patients. Anemia was defined as a hae-
moglobin concentration < 12 g/L in women and < 13 g/L in men. The
impact of NYHA class and congestive status in haemoglobin concentra-
tions are summarized in the table.
Conclusions: Congestive status impacts haemoglobin concentrations more
than the severity of CHF estimated by NYHA class. Haemodilution is an
important aetiology of anaemia in CHF, thus haemoglobin concentration
should be evaluated if possible in patients without congestive signs.
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Left ventricular systolic function and Response to Cardiac Resyn-
chronization Therapy is influenced by Right ventricular function as
assessed by Echocardiography
Anne Bernard, Erwan Donal, Christophe Thébault, Romain Ollivier, Jean-
Claude Daubert, Philipe Mabo, Christophe Leclercq
CHU RENNES, Cardiologie, Rennes, France
Background: Right ventricular (RV) function has been proven to be a
major determinant of clinical outcome in Chronic Heart Failure (CHF). The
right and left (L) ventricles inter dependence has been weakly evaluated but
might impact on response to treatments and prognosis.
Aim: We sought to assess the impact of RV-function on LV-function by
studying longitudinal and radial strains in CHF-patients selected for cardiac
resynchronization therapy (CRT).
Methods: Thirty-eight consecutive CHF-patients (New York Heart
Association class III/IV, left ventricular ejection fraction [LVEF] less than
35%, QRS greater than 120 ms) were studied before and after 6-month of
CRT. RV function was assessed by tricuspid annulus plane systolic
velocity (Vs) with a cut-off of 11.5 cm/s. Global LV longitudinal strain
(GLS) was measured (from the apical 4-chamber, apical 3-chamber and
apical 2-chamber views) before and after CRT. Mean radial strain was
measured from the parasternal mid-ventricular view. Reverse remodeling
was defined by echocardiography at 6-month by a decrease in LV end-sys-
tolic volume ≥ 15%.
Results: Eighteen patients had RV-dysfunction (mean Vs=7.6 ±1.2cm/
s) and 20 had normal RV-function (13.6±2.7cm/s). LVEF and volumes
were non different between groups. Patients with RV-dysfunction had sig-
nificantly worst global longitudinal strain before CRT (A-4Ch=-5.3±1.5%
vs. -7.4±2.2%, p=0.01; A-2Ch=-5.7±1.2% vs. -9±2%, p<0.01; A-3Ch=-
5±0.9% vs. -8.4±2.2%, p<0.01). After CRT, differences in global longitu-
dinal strain were still significant. Considering mean radial strain, there
were no differences between groups. The likelihood of response to CRT
was significantly worse in patients having a RV dysfunction (75% vs.
44%, p<0.05).
Conclusion: RV dysfunction diagnosed in patients planed for CRT is asso-
ciated with a significantly worse LV global longitudinal function and a signif-
icantly weak likelihood of response to CRT at 6-month.
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Primary prevention for heart failure among old hypertensive
patients: Contribution and perspectives derived from recent trials
François Dievart (1), Olivier Hanon (2)
(1) Clinique Villette, Dunkerque, France – (2) Hôpital Broca, Paris,
France
Background: In 2009, in France, heart failure (HF) affects around 1 000
000 Pts and is the first cause of hospitalization among patients (Pts) above
80 years of age. Despite constant progresses, results of HF secondary man-
agement are still moderate. Mortality rates decrease slowly, remaining
around 30 to 40% at 1year and reaching 70% at 5 years. Primary prevention
of HF could therefore be an effective strategy. In particular, hypertension
(HT) is strongly associated with HF. Meta-analyses (MA) demonstrated a
correlation, even not linear, between blood pressure (BP) decrease and HF
risk, suggesting different impacts of anti-HT strategies. In the ALLHAT
trial, the lowest rates of hospitalization and fatal HF were found for Pts
receiving diuretic or ACE inhibitor.
Methods: INDANA MA data, assessed among 1 670 Pts above 80, have
been compared to the recent, randomized, double-blind, multicentric HYVET
trial results. HYVET evaluated the benefits of treating 3845 Pts ≥ 80 years
with a sustained systolic BP≥160 mmHg using indapamide +/- perindopril
strategy (I-PS) or placebo.
Results: INDANA results showed a significant 39% reduction of HF
associated with a 6% relative excess of death from all causes in active
group. In HYVET, active treatment was associated with a 21% reduction
of all causes death (p=0,02) and a significant 64% reduction of HF (p <
0,001), with an incidence decreasing from 1,48% to 0,53% per year.
According to published figures, one HF would be prevented by treating 52
Pts during 2 years.
Conclusion: these results provide evidence that I-PS in HT Pts above 80 is
beneficial and effective for preventing HF and mortality. These results, if
applied to French population, could contribute to a significant reduction of HF
incidence among old HT patients.
Haemoglobin 
(g/L) NYHA I
NYHA II 
without 
congestive 
signs
NYHA II 
with 
congestive 
signs
NYHA III NYHA IV
n 107 448 62 295 37
Men 13.3 ± 1.6 13.4 ± 1.7 12.1 ± 1.9 12.7 ± 1.8 13.4 ± 1.6
Women 12.7 ± 1.2 12.6 ± 1.3 11.8 ± 2.5 12.1 ± 1.6 12.2 ± 2.1
Anaemia N (%) 33 (30.8) 150 (33.5) 42 (67.7)** 149 (50.5)* 15 (40.5)
* p < 0.05: NYHA III vs NYHA I,II / 
** p < 0.05 : NYHA II with congestive signs vs NYHA I,II 
without congestive signs III,IV.
